Low-Dose Doxazosin Improved Aortic Stiffness and Endothelial Dysfunction as Measured by Noninvasive Evaluation-Reference-Cited by-同舟云学术

Low-Dose Doxazosin Improved Aortic Stiffness and Endothelial Dysfunction as Measured by Noninvasive Evaluation

Published:2002 Issue:1 Volume:25 Page:5-10
ISSN:0916-9636
Container-title:Hypertension Research
language:
Short-container-title:Hypertens Res

Author:

KOMAI Norio,OHISHI Mitsuru,MORIGUCHI Atsushi,YANAGITANI Yoshihiro,JINNO Toyohisa,MATSUMOTO Keiko,KATSUYA Tomohiro,RAKUGI Hiromi,HIGAKI Jitsuo,OGIHARA Toshio

Publisher

Japanese Society of Hypertension

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference16 articles.

1. Noninvasive, Continuous Evaluation of Peripheral Vascular Resistance in Humans.

2. Effect of Doxazosin on Endothelial Dysfunction in Hypercholesterolemic/Antioxidant-Deficient Rats

3. Effects of doxazosin on atherosclerosis in cholesterol-fed rabbits

4. Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters

5. Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of selective alpha-1 receptor antagonist on arterial stiffness parameters in patients with benign prostate hyperplasia;2024-02-20

2. Aging of the Arterial System;International Journal of Molecular Sciences;2023-04-07

3. Autonomic and neuroendocrine modulation of arterial stiffness and hemodynamics;Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease;2022

4. Sympathetic neural modulation of arterial stiffness in humans;American Journal of Physiology-Heart and Circulatory Physiology;2020-12-01

5. A randomised, factorial trial to reduce arterial stiffness independently of blood pressure: Proof of concept? The VaSera trial testing dietary nitrate and spironolactone;British Journal of Clinical Pharmacology;2020-02-22